| Literature DB >> 35449854 |
Shizhen Bao1, Wenjia Liu1, Li Liu1, Guifen Jiang1, Huan Chen1.
Abstract
To investigate the characteristics of psychological symptoms in inflammatory bowel disease (IBD), to study the relationship between psychological symptoms and quality of life, and to provide some theoretical basis for the corresponding psychological treatment of IBD patients with psychiatric abnormalities. With the development of artificial intelligence (AI) and its gradual application to the medical field, it has brought new ideas to the medical development, and its research and application in IBD, including ulcerative colitis (UC) and Crohn's disease (CD), is increasing. Machine learning is used to select reasonable models and methods to help the prediction, diagnosis, treatment, and prognosis of IBD. In this study, we improved on the classical unidirectional LSTM model by adding backward and forward LSTM layers, designed a bidirectional LSTM model to improve the shortcomings of unidirectional LSTM with insufficient dependence on the posterior, introduced the contribution rate α to adjust the weight matrix of the forward LSTM layer and the backward LSTM layer, and experimentally verified the correctness and superiority of the proposed model. A total of 159 patients with IBD and 89 healthy people were collected and psychologically assessed using the general status questionnaire, the 90-item symptom checklist (SCL-90). Patients with IBD are prone to a combination of obsessive-compulsive, interpersonal, depressive, hostile, and other abnormal psychological symptoms, and their quality of life is significantly reduced; quality of life is mainly affected by disease condition, depression, interpersonal sensitivity, and paranoia, and patients in the active stage of the disease with heavy symptoms of depression, paranoia, and interpersonal sensitivity have low quality of life.Entities:
Mesh:
Year: 2022 PMID: 35449854 PMCID: PMC9017441 DOI: 10.1155/2022/7702432
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 3.822
Figure 1Simple diagram of the bidirectional LSTM neural network model.
Comparison of SCL-90 factor positivity in the IBD group and control group (n, percentage (%)).
| Project | IBD ( | Control group ( |
|
|
|---|---|---|---|---|
| Somatization | 19 | 2 | 6.93 | <0.01 |
| Force | 65 | 29 | 1.67 | >0.05 |
| Interpersonal relationship | 53 | 18 | 4.8 | <0.05 |
| Depressed | 50 | 14 | 7.36 | <0.01 |
| Anxious | 25 | 9 | 1.52 | >0.05 |
| Hostile | 46 | 10 | 10.22 | <0.01 |
| Fear | 13 | 2 | 3.53 | >0.05 |
| Paranoid | 41 | 11 | 6.21 | <0.01 |
| Psychotic | 19 | 6 | 1.71 | >0.05 |
| Others | 39 | 10 | 6.36 | <0.05 |
| Total score | 48 | 13 | 7.47 | <0.01 |
Comparison of SF-36 scores between the IBD group and the control group (, scores).
| Grouping |
| Physiological function | Physiological function | Pain | Commonly | Vitality | Sociology | Emotion | Spirit | Total score |
|---|---|---|---|---|---|---|---|---|---|---|
| IBD group | 159 | 83.08 ± 12.94 | 43.24 ± 41.12 | 62.71 ± 23.21 | 45.24 ± 18.92 | 43.02 ± 9.2 | 66.82 ± 22.19 | 57.23 ± 37.34 | 60.7 ± 12.59 | 56.47 ± 10.51 |
| Control group | 89 | 158.906 ± 28.49 | 21.84 ± 5.77 | 82.97 ± 15.98 | 74.33 ± 17.35 | 47.47 ± 10.95 | 87.5 ± 14.23 | 77.15 ± 37.81 | 60.54 ± 12.68 | 68.84 ± 8.55 |
|
| — | 4.74 | 8.54 | 6.23 | 11.96 | 3.41 | 7.92 | 4 | 0.1 | 9.48 |
|
| — | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.05 | <0.01 |
Comparison of IBDQ in SCL-90 positive and negative IBD patients (, scores).
| Grouping |
| Total score | Whole body | Intestine | Emotion | Sociology |
|---|---|---|---|---|---|---|
| SCL-90 negative | 63 | 177.98 ± 27.59 | 26.84 ± 5.45 | 57.85 ± 10.26 | 67.23 ± 9.37 | 26.04 ± 6.80 |
| SCL-90 positive | 96 | 158.90 ± 28.49 | 21.84 ± 5.77 | 53.41 ± 10.06 | 59.45 ± 10.57 | 24.18 ± 6.69 |
|
| — | 4.18 | 5.45 | 2.71 | 4.74 | 1.7 |
|
| — | <0.01 | <0.01 | <0.01 | <0.01 | >0.05 |
Figure 2Status of different patients.
Figure 3Histogram of the distribution of the influence of factors.
Figure 4Quality of life factors for patients with IBD.